Skip to content

Effect of Intravenous Lidocaine Infusion on Postoperative Early Recovery Quality in Cesarean Section

Effect of Intravenous Lidocaine Infusion on Postoperative Early Recovery Quality in Cesarean Section

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200056069
Enrollment
Unknown
Registered
2022-01-31
Start date
2022-02-26
Completion date
Unknown
Last updated
2024-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative management

Interventions

Experimental group :Intravenous infusion of lidocaine

Sponsors

Huai'an Maternal and Child Health Care Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: 1.ASA grade I and II; 2.Age 18-35 years; 3.BMI 18-35 kg/m^2; 4.Patients undergoing elective cesarean section.

Exclusion criteria

Exclusion criteria: 1.Allergic to local anesthetics; 2.Long-term use of analgesics or cortisol drugs; 3.Bradycardia; 4.Uncontrolled hypertension, 5.Significant heart, kidney, or liver disease; 6.Suffering from endocrine and metabolic diseases and nervous system diseases; 7.Previous history of alcohol addiction.

Design outcomes

Primary

MeasureTime frame
The Quality of Recovery-40 questionnaire;

Secondary

MeasureTime frame
Number of times to press the analgesic pump;Incidence of postoperative nausea and vomiting;Numeric rating scales;Intraoperative vasoactive drug dosage;

Countries

China

Contacts

Public ContactJian Sun

Huai'an maternal and child health care hospital

1014996241@qq.com+86 15996168372

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026